We are delighted to announce the appointment of Stephen Over as the Company's Chief Financial Officer and new member of the Executive team.
Stephen brings a wealth of senior leadership and strategic financing expertise with over 10 years of experience in the pharmaceuticals, biotech and medical devices industries.
NeoPhore's CEO - Michael Shih - recently presented the NeoPhore story at the Morgan Stanley Global Healthcare Conference on Monday September 8th…
NeoPhore appoints Michael Shih as Chief Executive Officer • Highly experienced corporate development leader with a track record of international p…
NeoPhore closes oversubscribed Series B extension round with additional funding from Bristol Myers Squibb Additional funding will be used to explore…